Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Rouen

About this trial

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Former or active intravenous and/or nasal drug user

Person on opiate substitution therapy

Disqualifiers

Person with known active viral infection(s)

Trial design

Design model

Single group

Treatments tested in this trial

  • Blood collection using Dried Blood Spot

    Diagnostic test

    Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection

Treatment groups

500 Participants
are divided into 1 treatment group
Group A: Drug userExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of person with an active hepatitis C infection

Time frame
Day 1
2

Number of person with an active hepatitis B infection

Time frame
Day 1
3

Number of person with an active AIDS infection

Time frame
Day 1

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.